Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
Adrian Traeger and colleagues report the development and validation of a prognostiv model (PICKUP) for estimating risk of developing chronic low back pain.
Vyšlo v časopise:
Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002019
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002019
Souhrn
Adrian Traeger and colleagues report the development and validation of a prognostiv model (PICKUP) for estimating risk of developing chronic low back pain.
Zdroje
1. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. doi: 10.1016/s0140-6736(15)60692-4 26063472
2. Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997–2006. Spine (Phila Pa 1976). 2009;34:2077–2084. doi: 10.1097/BRS.0b013e3181b1fad1
3. Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344:363–370. doi: 10.1056/NEJM200102013440508 11172169
4. Hong J, Reed C, Novick D, Happich M. Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database. Spine (Phila Pa 1976). 2013;38:75–82. doi: 10.1097/BRS.0b013e318276450f
5. Schofield DJ, Shrestha RN, Passey ME, Earnest A, Fletcher SL. Chronic disease and labour force participation among older Australians. Med J Aust. 2008;189:447. 18928439
6. Schofield DJ, Callander EJ, Shrestha RN, Percival R, Kelly SJ, Passey ME. Labor force participation and the influence of having back problems on income poverty in Australia. Spine (Phila Pa 1976). 2012;37:1156–1163. doi: 10.1097/BRS.0b013e31824481ee
7. Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA. 2010;303:1295–1302. doi: 10.1001/jama.2010.344 20371789
8. Menezes Costa LC, Maher CG, Hancock MJ, McAuley JH, Herbert RD, Costa LO. The prognosis of acute and persistent low-back pain: a meta-analysis. CMAJ. 2012;184:E613–E624. doi: 10.1503/cmaj.111271 22586331
9. Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976). 2012;37:E668–E677. doi: 10.1097/BRS.0b013e318241e5de
10. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169:251–258. doi: 10.1001/archinternmed.2008.543 19204216
11. Kamper SJ, Apeldoorn A, Chiarotto A, Smeets R, Ostelo R, Guzman J, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444. doi: 10.1136/bmj.h444 25694111
12. Linton SJ. Early identification and intervention in the prevention of musculoskeletal pain. Am J Ind Med. 2002;41:433–442. 12071495
13. Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10:e1001381. doi: 10.1371/journal.pmed.1001381 23393430
14. McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, et al. Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ. 2016;352:i348. doi: 10.1136/bmj.i348 26850726
15. Glasziou P, Moynihan R, Richards T, Godlee F. Too much medicine; too little care. BMJ. 2013;347:f4247. doi: 10.1136/bmj.f4247 23820022
16. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307:1513–1516. doi: 10.1001/jama.2012.362 22419800
17. Hudis CA. Trastuzumab—mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39–51. doi: 10.1056/NEJMra043186 17611206
18. Hingorani AD, Hemingway H. How should we balance individual and population benefits of statins for preventing cardiovascular disease? BMJ. 2011;342:c6244. doi: 10.1136/bmj.c6244
19. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332:1430–1434. doi: 10.1136/bmj.332.7555.1430 16777886
20. Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378:1560–1571. doi: 10.1016/s0140-6736(11)60937-9 21963002
21. Haskins R, Osmotherly PG, Rivett DA. Validation and impact analysis of prognostic clinical prediction rules for low back pain is needed: a systematic review. J Clin Epidemiol. 2015;68:821–832. doi: 10.1016/j.jclinepi.2015.02.003 25804336
22. Traeger AC, Moseley GL, Hubscher M, Lee H, Skinner IW, Nicholas MK, et al. Pain education to prevent chronic low back pain: a study protocol for a randomised controlled trial. BMJ Open. 2014;4:e005505. doi: 10.1136/bmjopen-2014-005505 24889854
23. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384:1586–1596. doi: 10.1016/s0140-6736(14)60805-9 25064594
24. Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: a systematic approach based on risk group. Trials. 2006;7:30. doi: 10.1186/1745-6215-7-30 17022818
25. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 2007;6:287–293. doi: 10.1038/nrd2251 17380152
26. Hill JC, Dunn KM, Lewis M, Mullis R, Main CJ, Foster NE, et al. A primary care back pain screening tool: identifying patient subgroups for initial treatment. Arthritis Rheum. 2008;59:632–641. doi: 10.1002/art.23563 18438893
27. Beneciuk JM, Bishop MD, Fritz JM, Robinson ME, Asal NR, Nisenzon AN, et al. The STarT back screening tool and individual psychological measures: evaluation of prognostic capabilities for low back pain clinical outcomes in outpatient physical therapy settings. Phys Ther. 2013;93:321–333. doi: 10.2522/ptj.20120207 23125279
28. Hockings RL, McAuley JH, Maher CG. A systematic review of the predictive ability of the Orebro Musculoskeletal Pain Questionnaire. Spine (Phila Pa 1976). 2008;33:E494–E500. doi: 10.1097/BRS.0b013e31817ba3bb
29. Kongsted A, Andersen CH, Hansen MM, Hestbaek L. Prediction of outcome in patients with low back pain—a prospective cohort study comparing clinicians’ predictions with those of the Start Back Tool. Man Ther. 2016;21:120–127. doi: 10.1016/j.math.2015.06.008 26144686
30. Mehling WE, Avins AL, Acree MC, Carey TS, Hecht FM. Can a back pain screening tool help classify patients with acute pain into risk levels for chronic pain? Eur J Pain. 2015;19:439–446. doi: 10.1002/ejp.615 25381748
31. Grotle M, Vollestad NK, Brox JI. Screening for yellow flags in first-time acute low back pain: reliability and validity of a Norwegian version of the Acute Low Back Pain Screening Questionnaire. Clin J Pain. 2006;22:458–467. doi: 10.1097/01.ajp.0000208243.33498.cb 16772801
32. Traeger A, Henschke N, Hubscher M, Williams CM, Kamper SJ, Maher CG, et al. Development and validation of a screening tool to predict the risk of chronic low back pain in patients presenting with acute low back pain: a study protocol. BMJ open. 2015;5:e007916. doi: 10.1136/bmjopen-2015-007916 26179647
33. Henschke N, Maher CG, Refshauge KM, Herbert RD, Cumming RG, Bleasel J, et al. Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study. BMJ. 2008;337:a171. doi: 10.1136/bmj.a171 18614473
34. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, et al. PACE—the first placebo controlled trial of paracetamol for acute low back pain: statistical analysis plan. Trials. 2013;14:248. doi: 10.1186/1745-6215-14-248 23937999
35. Henschke N, Maher CG, Refshauge KM, Herbert RD, Cumming RG, Bleasel J, et al. Prognosis of acute low back pain: design of a prospective inception cohort study. BMC Musculoskelet Disord. 2006;7:54. 16790069
36. Steenstra I, Verbeek J, Heymans M, Bongers P. Prognostic factors for duration of sick leave in patients sick listed with acute low back pain: a systematic review of the literature. Occup Environ Med. 2005;62:851–860. 16299094
37. Bekkering GE, Hendriks HJ, van Tulder MW, Knol DL, Simmonds MJ, Oostendorp RA, et al. Prognostic factors for low back pain in patients referred for physiotherapy: comparing outcomes and varying modeling techniques. Spine (Phila Pa 1976). 2005;30:1881–1886.
38. Pincus T, Burton AK, Vogel S, Field AP. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine (Phila Pa 1976). 2002;27:E109–E120.
39. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483. 1593914
40. de Vet HC, Heymans MW, Dunn KM, Pope DP, van der Beek AJ, Macfarlane GJ, et al. Episodes of low back pain: a proposal for uniform definitions to be used in research. Spine (Phila Pa 1976). 2002;27:2409–2416. doi: 10.1097/01.brs.0000030307.34002.be
41. Moseley GL, Herbert RD, Parsons T, Lucas S, Van Hilten JJ, Marinus J. Intense pain soon after wrist fracture strongly predicts who will develop complex regional pain syndrome: prospective cohort study. J Pain. 2014;15:16–23. doi: 10.1016/j.jpain.2013.08.009 24268113
42. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer Science & Business Media; 2008.
43. Box GE, Tidwell PW. Transformation of the independent variables. Technometrics. 1962;4:531–550.
44. Becker A, Held H, Redaelli M, Strauch K, Chenot JF, Leonhardt C, et al. Low back pain in primary care: costs of care and prediction of future health care utilization. Spine (Phila Pa 1976). 2010;35:1714–1720.
45. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546. 7069920
46. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology. 2010;21:128–138. doi: 10.1097/EDE.0b013e3181c30fb2 20010215
47. Gerds TA, Cai T, Schumacher M. The performance of risk prediction models. Biom J. 2008;50:457–479. doi: 10.1002/bimj.200810443 18663757
48. Harrell F, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387. 8668867
49. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans M, Vergouwe Y, Habbema JDF. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774–781. 11470385
50. Alsaadi SM, McAuley JH, Hush JM, Lo S, Lin CWC, Williams CM, et al. Poor sleep quality is strongly associated with subsequent pain intensity in patients with acute low back pain. Arthritis Rheum. 2014;66:1388–1394.
51. Aili K, Nyman T, Hillert L, Svartengren M. Sleep disturbances predict future sickness absence among individuals with lower back or neck-shoulder pain: a 5-year prospective study. Scand J Public Health. 2015;43:315–323. doi: 10.1177/1403494814567755 25724467
52. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–574. doi: 10.1177/0272989x06295361 17099194
53. Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014.
54. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19:2075–2094. doi: 10.1007/s00586-010-1502-y 20602122
55. Riley RD, Hayden JA, Steyerberg EW, Moons KGM, Abrams K, Kyzas PA, et al. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10:e1001380. doi: 10.1371/journal.pmed.1001380 23393429
56. Hingorani AD, Windt DA, Riley RD, Abrams K, Moons KG, Steyerberg EW, et al. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ. 2013;346:e5793. doi: 10.1136/bmj.e5793 23386361
57. Steyerberg EW, Ewout WS. Clinical prediction models: a practical approach to development, validation, and updating. Dordrecht: Springer; 2008.
58. Austin PC, Tu JV. Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol. 2004;57:1138–1146. 15567629
59. Hancock M, Maher C, Petocz P, Lin CC, Steffens D, Luque-Suarez A, et al. Risk factors for a recurrence of low back pain. Spine J. 2015;15:2360–2368. doi: 10.1016/j.spinee.2015.07.007 26169027
60. Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet. 2009;373:463–472. doi: 10.1016/s0140-6736(09)60172-0 19200918
61. Janssen KJ, Donders ART, Harrell FE, Vergouwe Y, Chen Q, Grobbee DE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63:721–727. doi: 10.1016/j.jclinepi.2009.12.008 20338724
62. Steyerberg EW, Vickers AJ. Decision curve analysis: a discussion. Med Decis Making. 2008;28:146. doi: 10.1177/0272989X07312725 18263565
63. Hush JM, Refshauge K, Sullivan G, De Souza L, Maher CG, McAuley JH. Recovery: what does this mean to patients with low back pain? Arthritis Rheum. 2009;61:124–131. doi: 10.1002/art.24162 19116958
64. Williams CM, Hancock MJ, Maher CG, McAuley JH, Lin CWC, Latimer J. Predicting rapid recovery from acute low back pain based on the intensity, duration and history of pain: a validation study. Eur J Pain. 2014;18:1182–1189. doi: 10.1002/j.1532-2149.2014.00467.x 24648103
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 5
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
- Prioritizing Surgical Care on National Health Agendas: A Qualitative Case Study of Papua New Guinea, Uganda, and Sierra Leone
- A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola